Loading insider details...
Latest Form 4 (Jun 23, 2026): Grant/Award of 144,400 ALLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 144,400 | n/a |
| Jun 6, 2026 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 16,875 | n/a |
| Jun 2, 2026 | Merck & Co., Inc. (MRK) | Grant/Award | 1,853 | $220.0K |
| Mar 14, 2026 | Sarepta Therapeutics, Inc. (SRPT) | Sale | 7,239 | $123.2K |
| Jun 24, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Jun 3, 2025 | Merck & Co., Inc. (MRK) | Grant/Award | 2,863 | $220.0K |
| Mar 12, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 2,383 | n/a |
| Jun 7, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 191,082 | n/a |
| Jun 4, 2024 | Merck & Co., Inc. (MRK) | Grant/Award | 1,752 | $220.0K |
| Mar 7, 2024 | Sarepta Therapeutics, Inc. (SRPT) | Sale | 3,135 | $385.5K |